Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies-Reference-Cited by-同舟云学术

Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies

Published:1999-06-01 Issue:11 Volume:93 Page:3587-3600
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Wickremasinghe R. Gitendra¹,Hoffbrand A. Victor¹

Affiliation:

1. From the Department of Hematology, Royal Free and University College School of Medicine, London, UK.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/93/11/3587/1654659/3587.pdf

Reference189 articles.

1. Apoptosis in cancer therapy: Crossing the threshold.;Fisher;Cell,1994

2. Apoptosis and the dilemma of cancer chemotherapy.;Hannun;Blood,1997

3. Apoptosis: Its significance in cancer and cancer therapy.;Kerr;Cancer,1994

4. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.;Fadok;J Immunol,1992

5. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of bcl-2 and abl.;Martin;J Exp Med,1995

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect and Mechanism of Specnuezhenide on Chemotherapy-induced Myelosuppression;Combinatorial Chemistry & High Throughput Screening;2023-11

2. Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis;Cancer and Metastasis Reviews;2020-02-04

3. Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide;Journal of Ginseng Research;2019-10

4. Antileukemic Treatment Targeted at Apoptosis Regulators;Innovative Leukemia and Lymphoma Therapy;2019-09-17

5. Inhibition of protein phosphatase 1 stimulates noncanonical ER stress eIF2α activation to enhance fisetin-induced chemosensitivity in HDAC inhibitor-resistant hepatocellular carcinoma cells;Cancers;2019-06-29